(RGR) Sturm Ruger - Overview
Stock: Rifles, Pistols, Revolvers, Accessories, Castings
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.68% |
| Yield on Cost 5y | 0.47% |
| Yield CAGR 5y | -32.76% |
| Payout Consistency | 71.1% |
| Payout Ratio | 63.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 27.6% |
| Relative Tail Risk | -19.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.33 |
| Alpha | 0.99 |
| Character TTM | |
|---|---|
| Beta | 0.367 |
| Beta Downside | 0.281 |
| Drawdowns 3y | |
|---|---|
| Max DD | 49.63% |
| CAGR/Max DD | -0.20 |
Description: RGR Sturm Ruger December 26, 2025
Sturm, Ruger & Company Inc. (NYSE:RGR) designs, manufactures and sells a full-range of firearms-including rifles, pistols, revolvers and accessories-under the Ruger and Marlin brands, and also produces steel investment castings and metal-injection-molded (MIM) parts.
The business is split into two reporting segments: Firearms, which serves the U.S. commercial sporting market through independent wholesale distributors and exports to law-enforcement and foreign government customers; and Castings, which sells investment castings and MIM components directly or via representatives.
Key recent performance indicators show FY 2023 revenue of roughly $1.8 billion, an operating margin of 12 percent, and diluted EPS of $5.30; Q2 2024 sales rose about 8 percent year-over-year while inventory days fell to 45, reflecting tighter supply-chain management.
Sector drivers remain the cyclical nature of discretionary consumer spending, U.S. civilian firearms demand that spikes during election cycles and heightened safety concerns, and broader macro-economic factors such as consumer confidence and interest-rate-sensitive financing for hunting and shooting sports equipment.
For a deeper quantitative breakdown, the ValueRay platform offers a granular view of Ruger’s valuation metrics.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 2.60m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 4.19 > 1.0 |
| NWC/Revenue: 27.63% < 20% (prev 36.92%; Δ -9.29% < -1%) |
| CFO/TA 0.17 > 3% & CFO 58.8m > Net Income 2.60m |
| Net Debt (-14.2m) to EBITDA (16.3m): -0.87 < 3 |
| Current Ratio: 3.54 > 1.5 & < 3 |
| Outstanding Shares: last quarter (16.4m) vs 12m ago -4.49% < -2% |
| Gross Margin: 16.16% > 18% (prev 0.22%; Δ 1594 % > 0.5%) |
| Asset Turnover: 151.1% > 50% (prev 139.4%; Δ 11.73% > 0%) |
| Interest Coverage Ratio: 14.42 > 6 (EBITDA TTM 16.3m / Interest Expense TTM 91.0k) |
Altman Z'' 10.00
| A: 0.44 (Total Current Assets 208.3m - Total Current Liabilities 58.9m) / Total Assets 342.3m |
| B: 1.22 (Retained Earnings 419.2m / Total Assets 342.3m) |
| C: 0.00 (EBIT TTM 1.31m / Avg Total Assets 357.9m) |
| D: 7.08 (Book Value of Equity 443.7m / Total Liabilities 62.7m) |
| Altman-Z'' Score: 14.31 = AAA |
Beneish M -2.86
| DSRI: 0.96 (Receivables 59.9m/60.2m, Revenue 540.8m/520.5m) |
| GMI: 1.35 (GM 16.16% / 21.80%) |
| AQI: 1.04 (AQ_t 0.14 / AQ_t-1 0.14) |
| SGI: 1.04 (Revenue 540.8m / 520.5m) |
| TATA: -0.16 (NI 2.60m - CFO 58.8m) / TA 342.3m) |
| Beneish M-Score: -2.86 (Cap -4..+1) = A |
What is the price of RGR shares?
Over the past week, the price has changed by +4.47%, over one month by +9.33%, over three months by +9.12% and over the past year by +9.52%.
Is RGR a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the RGR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 44.5 | 16.1% |
| Analysts Target Price | 44.5 | 16.1% |
| ValueRay Target Price | 38 | -1% |
RGR Fundamental Data Overview February 03, 2026
P/S = 0.8115
P/B = 2.1126
Revenue TTM = 540.8m USD
EBIT TTM = 1.31m USD
EBITDA TTM = 16.3m USD
Long Term Debt = 1.27m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 637.0k USD (from shortTermDebt, last quarter)
Debt = 1.91m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -14.2m USD (from netDebt column, last quarter)
Enterprise Value = 514.1m USD (593.0m + Debt 1.91m - CCE 80.8m)
Interest Coverage Ratio = 14.42 (Ebit TTM 1.31m / Interest Expense TTM 91.0k)
EV/FCF = 12.09x (Enterprise Value 514.1m / FCF TTM 42.5m)
FCF Yield = 8.27% (FCF TTM 42.5m / Enterprise Value 514.1m)
FCF Margin = 7.86% (FCF TTM 42.5m / Revenue TTM 540.8m)
Net Margin = 0.48% (Net Income TTM 2.60m / Revenue TTM 540.8m)
Gross Margin = 16.16% ((Revenue TTM 540.8m - Cost of Revenue TTM 453.4m) / Revenue TTM)
Gross Margin QoQ = 15.11% (prev 3.88%)
Tobins Q-Ratio = 1.50 (Enterprise Value 514.1m / Total Assets 342.3m)
Interest Expense / Debt = 0.89% (Interest Expense 17.0k / Debt 1.91m)
Taxrate = 19.09% (7.21m / 37.8m)
NOPAT = 1.06m (EBIT 1.31m * (1 - 19.09%))
Current Ratio = 3.54 (Total Current Assets 208.3m / Total Current Liabilities 58.9m)
Debt / Equity = 0.01 (Debt 1.91m / totalStockholderEquity, last quarter 279.6m)
Debt / EBITDA = -0.87 (Net Debt -14.2m / EBITDA 16.3m)
Debt / FCF = -0.33 (Net Debt -14.2m / FCF TTM 42.5m)
Total Stockholder Equity = 302.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.73% (Net Income 2.60m / Total Assets 342.3m)
RoE = 0.86% (Net Income TTM 2.60m / Total Stockholder Equity 302.5m)
RoCE = 0.43% (EBIT 1.31m / Capital Employed (Equity 302.5m + L.T.Debt 1.27m))
RoIC = 0.35% (NOPAT 1.06m / Invested Capital 302.5m)
WACC = 7.25% (E(593.0m)/V(594.9m) * Re(7.27%) + D(1.91m)/V(594.9m) * Rd(0.89%) * (1-Tc(0.19)))
Discount Rate = 7.27% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -3.76%
[DCF Debug] Terminal Value 73.79% ; FCFF base≈37.8m ; Y1≈24.8m ; Y5≈11.3m
Fair Price DCF = 16.94 (EV 255.9m - Net Debt -14.2m = Equity 270.1m / Shares 15.9m; r=7.25% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -90.84 | EPS CAGR: -60.76% | SUE: -2.90 | # QB: 0
Revenue Correlation: -67.93 | Revenue CAGR: -7.24% | SUE: 0.21 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.37 | Chg30d=-0.090 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=1.92 | Chg30d=-0.165 | Revisions Net=-1 | Growth EPS=+1300.0% | Growth Revenue=+2.3%